BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Netzler NE, Enosi Tuipulotu D, White PA. Norovirus antivirals: Where are we now? Med Res Rev 2019;39:860-86. [PMID: 30584800 DOI: 10.1002/med.21545] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Huang Y, Zhou N, Zhang S, Yi Y, Han Y, Liu M, Han Y, Shi N, Yang L, Wang Q, Cui T, Jin H. Norovirus detection in wastewater and its correlation with human gastroenteritis: a systematic review and meta-analysis. Environ Sci Pollut Res. [DOI: 10.1007/s11356-021-18202-x] [Reference Citation Analysis]
2 Esposito S, Principi N. Norovirus Vaccine: Priorities for Future Research and Development. Front Immunol 2020;11:1383. [PMID: 32733458 DOI: 10.3389/fimmu.2020.01383] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
3 Müller-Hermes C, Creutznacher R, Mallagaray A. Complete assignment of Ala, Ile, LeuProS, Met and ValProS methyl groups of the protruding domain from human norovirus GII.4 Saga. Biomol NMR Assign 2020;14:123-30. [PMID: 31993958 DOI: 10.1007/s12104-020-09932-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ferla S, Varricchio C, Knight W, Ho PK, Saporito F, Tropea B, Fagan G, Flude BM, Bevilacqua F, Santos-Ferreira N, Van Dycke J, Neyts J, Brancale A, Rocha-Pereira J, Bassetto M. Structure-Activity Relationship Studies on Novel Antiviral Agents for Norovirus Infections. Microorganisms 2021;9:1795. [PMID: 34576691 DOI: 10.3390/microorganisms9091795] [Reference Citation Analysis]
5 Enosi Tuipulotu D, Fumian TM, Netzler NE, Mackenzie JM, White PA. The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses. Viruses 2019;11:E496. [PMID: 31151251 DOI: 10.3390/v11060496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
6 Kondapi DS, Ramani S, Estes MK, Atmar RL, Okhuysen PC. Norovirus in Cancer Patients: A Review. Open Forum Infect Dis 2021;8:ofab126. [PMID: 34189156 DOI: 10.1093/ofid/ofab126] [Reference Citation Analysis]
7 Ebenezer O, Jordaan MA, Damoyi N, Shapi M. Discovery of Potential Inhibitors for RNA-Dependent RNA Polymerase of Norovirus: Virtual Screening, and Molecular Dynamics. Int J Mol Sci 2020;22:E171. [PMID: 33375298 DOI: 10.3390/ijms22010171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Maduray K, Parboosing R. Metal Nanoparticles: a Promising Treatment for Viral and Arboviral Infections. Biol Trace Elem Res 2021;199:3159-76. [PMID: 33029761 DOI: 10.1007/s12011-020-02414-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Han JC, Li QX, Fang JB, Zhang JY, Li YQ, Li SZ, Cheng C, Xie CZ, Nan FL, Zhang H, Li ZX, Jin NY, Zhu GZ, Lu HJ. GII.P16-GII.2 Recombinant Norovirus VLPs Polarize Macrophages Into the M1 Phenotype for Th1 Immune Responses. Front Immunol 2021;12:781718. [PMID: 34868056 DOI: 10.3389/fimmu.2021.781718] [Reference Citation Analysis]
10 van Loben Sels JM, Green KY. The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics. Viruses 2019;11:E432. [PMID: 31083353 DOI: 10.3390/v11050432] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
11 Li Q, Groaz E, Rocha-Pereira J, Neyts J, Herdewijn P. Anti-norovirus activity of C7-modified 4-amino-pyrrolo[2,1-f][1,2,4]triazine C-nucleosides. Eur J Med Chem 2020;195:112198. [PMID: 32294613 DOI: 10.1016/j.ejmech.2020.112198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Netzler NE, Enosi Tuipulotu D, White PA. Norovirus antivirals: Where are we now? Med Res Rev 2019;39:860-86. [PMID: 30584800 DOI: 10.1002/med.21545] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
13 Tan MTH, Li Y, Eshaghi Gorji M, Gong Z, Li D. Fucoidan But Not 2'-Fucosyllactose Inhibits Human Norovirus Replication in Zebrafish Larvae. Viruses 2021;13:461. [PMID: 33799811 DOI: 10.3390/v13030461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ludwig-Begall LF, Mauroy A, Thiry E. Noroviruses-The State of the Art, Nearly Fifty Years after Their Initial Discovery. Viruses 2021;13:1541. [PMID: 34452406 DOI: 10.3390/v13081541] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Van Dycke J, Puxeddu M, La Regina G, Mastrangelo E, Tarantino D, Rymenants J, Sebastiani J, Nalli M, Matthijnssens J, Neyts J, Silvestri R, Rocha-Pereira J. Discovery of a Novel Class of Norovirus Inhibitors with High Barrier of Resistance. Pharmaceuticals (Basel) 2021;14:1006. [PMID: 34681230 DOI: 10.3390/ph14101006] [Reference Citation Analysis]
16 Sohrabi F, Saeidifard S, Ghasemi M, Asadishad T, Hamidi SM, Hosseini SM. Role of plasmonics in detection of deadliest viruses: a review. Eur Phys J Plus 2021;136:675. [PMID: 34178567 DOI: 10.1140/epjp/s13360-021-01657-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]